標題: Titlebook: Breast Cancer: From Bench to Personalized Medicine; Saima Shakil Malik,Nosheen Masood Book 2022 The Editor(s) (if applicable) and The Auth [打印本頁] 作者: VIRAL 時間: 2025-3-21 17:23
書目名稱Breast Cancer: From Bench to Personalized Medicine影響因子(影響力)
書目名稱Breast Cancer: From Bench to Personalized Medicine影響因子(影響力)學科排名
書目名稱Breast Cancer: From Bench to Personalized Medicine網(wǎng)絡公開度
書目名稱Breast Cancer: From Bench to Personalized Medicine網(wǎng)絡公開度學科排名
書目名稱Breast Cancer: From Bench to Personalized Medicine被引頻次
書目名稱Breast Cancer: From Bench to Personalized Medicine被引頻次學科排名
書目名稱Breast Cancer: From Bench to Personalized Medicine年度引用
書目名稱Breast Cancer: From Bench to Personalized Medicine年度引用學科排名
書目名稱Breast Cancer: From Bench to Personalized Medicine讀者反饋
書目名稱Breast Cancer: From Bench to Personalized Medicine讀者反饋學科排名
作者: 不可侵犯 時間: 2025-3-21 23:22 作者: BLAND 時間: 2025-3-22 02:34 作者: 誤傳 時間: 2025-3-22 07:33
Cancer Care and Psychosocial Needs with family, friends, and others. Cancer patients are at risk for long-term physical impairment, disability, and inability to perform everyday tasks, as well as psychological and social issues that may arise as a result of the diagnosis and its sequelae. Many cancer survivors claim that their careg作者: 含糊 時間: 2025-3-22 09:27 作者: Processes 時間: 2025-3-22 16:26
Early-Stage Progression of Breast Cancerone of the most common cancers and is the main cause of cancer deaths in women. As compared to developing countries, developed countries showed higher prevalence rate of cancerous cells of breast among women. There are five different stages of breast cancer. The proliferation of breast cells can sta作者: 微粒 時間: 2025-3-22 17:23 作者: 膠水 時間: 2025-3-22 21:49 作者: 全部 時間: 2025-3-23 03:01 作者: Humble 時間: 2025-3-23 06:12 作者: PET-scan 時間: 2025-3-23 12:30 作者: Minutes 時間: 2025-3-23 14:12 作者: CULP 時間: 2025-3-23 20:37 作者: Spina-Bifida 時間: 2025-3-23 23:17
Utility of Personalized Medicine in the Treatment of Different Subtypes of Breast Cancer genes and protein pathways. The personalized medicine vision, where genomic and proteomic of individual is used to predict risks of diseases and responsiveness to drugs, revolutionized the medical management of BC. The phenomenon has increasingly gained popularity due to its potential for developin作者: 分期付款 時間: 2025-3-24 05:53 作者: Exclude 時間: 2025-3-24 07:24 作者: CANDY 時間: 2025-3-24 14:22
epigenetic modifications in breast cancer initiation and proThis book provides detailed information on the etiology, pathogenesis, diagnosis, prognosis, and treatment strategies for breast cancer. The first section of the book presents epidemiology, risk factors, histopathological, immunohistochemis作者: inveigh 時間: 2025-3-24 18:51 作者: 努力趕上 時間: 2025-3-24 19:17 作者: AWRY 時間: 2025-3-25 00:22 作者: Gorilla 時間: 2025-3-25 04:14
ribose) polymerase (PARP) inhibitors to treat breast cancer. Finally, it offers potential new options for personalized therapies for breast cancer patients, including optimizing drug dosage and identifying gene978-981-19-0199-7978-981-19-0197-3作者: Resign 時間: 2025-3-25 09:19 作者: coalition 時間: 2025-3-25 14:33
Carolin Maja Gebhardt,Dominik Niopeko manifestation of disease for almost 40?years of the age. Some of the significant contributing factors of the disease include harmful alcohol use, age, obesity, family history, exposure to harmful radiations, and reproductive factors. Besides, some factors are responsible for aggravating the incide作者: BOGUS 時間: 2025-3-25 16:33 作者: 慎重 時間: 2025-3-25 21:39
The TRPCs–STIM1–Orai Interactionn this chapter. The genetic basis for hormone-dependent tumors, relationships between breast and other hormonal cancer, and biomarker correlation that has recently been recognized are also covered in this chapter.作者: Semblance 時間: 2025-3-26 01:31 作者: magnate 時間: 2025-3-26 05:47 作者: 圖畫文字 時間: 2025-3-26 09:05
https://doi.org/10.1007/978-3-642-54215-2motherapy is affected due to the cancer characteristics and by molecular classification. Molecular classification of breast cancer based on estrogen receptor negative group such as HER2 enriched, normal breast, and basal shaped is more sensitive to chemotherapy as compared to estrogen receptor posit作者: Synovial-Fluid 時間: 2025-3-26 12:46 作者: 話 時間: 2025-3-26 18:40
Victor J. Wilson,Geoffrey Melvill Jonesence of the DNA, making them not only an attractive candidate as a prognostic and diagnostic biomarker but also a potential therapeutic target. Aberrant epigenetic modifications, namely, histone modifications, DNA methylation, and non-coding RNAs (ncRNAs) have a crucial role in initiating breast car作者: evasive 時間: 2025-3-26 22:53 作者: dermatomyositis 時間: 2025-3-27 03:41 作者: epicardium 時間: 2025-3-27 09:22
Izabela Gutowska,Monika Ra?,Dariusz Chlubek lipids present in a confined biological sample are quantified with the help of analytical instruments. Lipidomics provide knowledge about promising biomarkers for detecting the type and degree of breast cancer. This chapter focuses on the study of lipid biomarkers from breast cancer tissues/plasma 作者: 過剩 時間: 2025-3-27 10:27 作者: 半導體 時間: 2025-3-27 16:04 作者: 休閑 時間: 2025-3-27 19:49 作者: 利用 時間: 2025-3-27 22:03
Gilbert H. Smith,Corinne A. Boulangery used therapeutic strategies depend upon the expression levels of PR, ER, and HER2. Even though the methods used for clinical classification help choose targeted therapies, the prediction of patient responses and their long-term survival remains difficult. Recent advances in the field of molecular 作者: 較早 時間: 2025-3-28 04:49
Epidemiology and Risk Factors of Breast Cancero manifestation of disease for almost 40?years of the age. Some of the significant contributing factors of the disease include harmful alcohol use, age, obesity, family history, exposure to harmful radiations, and reproductive factors. Besides, some factors are responsible for aggravating the incide作者: Excise 時間: 2025-3-28 08:16
Histopathological Characteristics: Breast Cancer Subtypes Depending on Receptor Status, Clinical andypes: tubular, mucinous, neuroendocrine, apocrine (androgen-receptor positive and estrogen-receptor negative), micropapillary, adenoid, cystic, metaplastic, and medullary carcinoma. Understanding of present study focused on invasive carcinoma with histological types and subtypes with detail origin o作者: Chagrin 時間: 2025-3-28 13:34 作者: Alveoli 時間: 2025-3-28 17:26
Cancer Care and Psychosocial Needslain the type of caring for a cancer patient entailed on a personal, relational, and socio-cultural level. The chapter will cover a wide range of topics, including the importance of personality and the psychological distress that cancer patients can encounter, as well as the caregiver’s critical pos作者: 缺乏 時間: 2025-3-28 21:38
Implications of BRCA1, BRCA2 Gene in Overall Development and Prognosis of Breast Cancerrapeutic preventative measures to guard against the disease. Classification and revelation of BRCA mutation-affected patients manipulate the options for treatment and impact the outcome of breast cancer survival,?and in addition could be a vital tool to identify their kins that harbor the inherited 作者: 雪崩 時間: 2025-3-29 00:20 作者: Adrenaline 時間: 2025-3-29 04:42
Noninvasive Biomarkers: Emerging Trends in Early Detection of Breast Cancerirate fluid (NAF), sweat, and urine have shown great potential to detect BC at pre-invasive stages. In addition, there is a superior requirement of mutational signature for individualized treatments; the high-penetrance molecular biomarkers including . risk alleles for the breast cancer progression.作者: 防水 時間: 2025-3-29 07:24 作者: heterogeneous 時間: 2025-3-29 12:07 作者: intellect 時間: 2025-3-29 19:01 作者: enflame 時間: 2025-3-29 22:36 作者: 領巾 時間: 2025-3-29 23:57
Therapeutic Options in BRCA1-Linked Breast Cancer and Systemic Approachesemoval of certain parts of the skin, some tissues, and lymph nodes from the chest wall for histopathological studies to find out whether there are any other cancerous cells. Removal of both ovaries and fallopian tubes due to the presence of ovarian cancer in case of hereditary mutation of . and . ge作者: 先兆 時間: 2025-3-30 07:41 作者: TOXIC 時間: 2025-3-30 10:37
Utility of Personalized Medicine in the Treatment of Different Subtypes of Breast Cancereventually lead to the creation of more tailored treatments for effective cancer therapy. The personalization of BC care is a major factor in improving outcomes, highlighting the significance of personalized medicines.作者: 喚起 時間: 2025-3-30 16:08 作者: resuscitation 時間: 2025-3-30 20:34 作者: 昏迷狀態(tài) 時間: 2025-3-30 22:14
Breast Cancer: From Bench to Personalized Medicine978-981-19-0197-3
